HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eloisa Bonfa Selected Research

Propiolactone

2/2022Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eloisa Bonfa Research Topics

Disease

16Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2022 - 09/2011
13Rheumatic Diseases (Rheumatism)
10/2022 - 06/2011
11Human Influenza (Influenza)
10/2018 - 01/2009
8Rheumatoid Arthritis
05/2022 - 12/2011
6Infections
08/2021 - 01/2009
6Juvenile Arthritis (Juvenile Idiopathic Arthritis)
02/2020 - 09/2013
6Ankylosing Spondylitis
01/2020 - 10/2012
4COVID-19
07/2022 - 01/2021
4Lupus Nephritis
07/2021 - 05/2020
4Pain (Aches)
09/2016 - 01/2010
3Proteinuria
07/2021 - 01/2019
3Hypertension (High Blood Pressure)
12/2020 - 09/2012
3Latent Tuberculosis
01/2020 - 09/2017
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2018 - 09/2012
2Systemic Scleroderma (Systemic Sclerosis)
05/2022 - 10/2018
2Peripheral Nervous System Diseases (PNS Diseases)
09/2021 - 05/2021
2Leukopenia
01/2020 - 01/2019
2Psoriatic Arthritis
01/2020 - 01/2020
2Tuberculosis (Tuberculoses)
09/2017 - 09/2014
2Dermatomyositis (Dermatopolymyositis)
05/2017 - 01/2016
2Low Back Pain (Lumbago)
09/2016 - 03/2016
2Inflammation (Inflammations)
10/2015 - 10/2012
2Hemorrhage
10/2015 - 12/2014
2Venous Thrombosis (Deep-Vein Thrombosis)
12/2014 - 09/2012
2Autoimmune Hepatitis
02/2014 - 07/2013
2Fibrosis (Cirrhosis)
07/2013 - 01/2010
1Autoimmune Diseases (Autoimmune Disease)
07/2022
1Atherosclerosis
05/2022
1Vasculitis (Vasculitides)
01/2022
1Necrosis
01/2022
1Polyneuropathies (Polyneuropathy)
09/2021
1Cicatrix (Scar)
09/2021
1Cutaneous Lupus Erythematosus
09/2021
1Body Weight (Weight, Body)
07/2021
1Venous Thromboembolism
01/2021
1malar rash
12/2020
1Renal Hypertension
12/2020
1Alopecia (Baldness)
12/2020
1Oral Ulcer (Mouth Ulcer)
12/2020

Drug/Important Bio-Agent (IBA)

12VaccinesIBA
01/2022 - 06/2011
11AntibodiesIBA
10/2022 - 09/2012
8sinovac COVID-19 vaccineIBA
10/2022 - 10/2021
6COVID-19 VaccinesIBA
05/2022 - 01/2022
5Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 12/2011
4Hydroxychloroquine (Plaquenil)FDA LinkGeneric
07/2022 - 05/2020
4Immunoglobulin G (IgG)IBA
05/2022 - 01/2020
4Prednisone (Sone)FDA LinkGeneric
01/2022 - 03/2017
4Antimalarials (Antimalarial Agents)IBA
12/2020 - 06/2012
4Proteins (Proteins, Gene)FDA Link
10/2020 - 07/2013
3Inactivated VaccinesIBA
05/2022 - 10/2021
3amsonic acid (DAS)IBA
02/2022 - 01/2009
3Antirheumatic Agents (DMARD)IBA
01/2022 - 03/2013
3GlucocorticoidsIBA
09/2021 - 01/2012
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2021 - 01/2010
3DNA (Deoxyribonucleic Acid)IBA
12/2020 - 01/2019
3CreatinineIBA
12/2020 - 01/2019
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 10/2012
3AutoantibodiesIBA
01/2019 - 07/2013
3Tumor Necrosis Factor InhibitorsIBA
12/2018 - 11/2012
2Leflunomide (Arava)FDA LinkGeneric
05/2022 - 02/2020
2Rituximab (Mabthera)FDA Link
05/2022 - 07/2021
2oxidized low density lipoproteinIBA
05/2022 - 01/2015
2HDL LipoproteinsIBA
05/2022 - 01/2015
2Abatacept (Orencia)FDA Link
01/2022 - 03/2013
2Thalidomide (Thalomid)FDA Link
09/2021 - 05/2021
2C-Reactive ProteinIBA
01/2021 - 09/2014
2Antiphospholipid AntibodiesIBA
12/2020 - 09/2012
2Pharmaceutical PreparationsIBA
01/2020 - 12/2018
2Insulin (Novolin)FDA Link
03/2016 - 10/2012
2Influenza Vaccines (Influenza Vaccine)FDA Link
11/2012 - 06/2011
1BNT162 VaccineIBA
05/2022
1Messenger RNA (mRNA)IBA
05/2022
1CholesterolIBA
05/2022
1PropiolactoneFDA Link
02/2022
1tofacitinibIBA
01/2022
1tocilizumab (atlizumab)FDA Link
01/2022
1Lenalidomide (CC 5013)FDA Link
09/2021
1AndrogensIBA
09/2021
1MineralocorticoidsIBA
09/2021
1Hormones (Hormone)IBA
09/2021
1alpha-DefensinsIBA
08/2021
1Calcineurin InhibitorsIBA
07/2021
1voclosporinIBA
07/2021
1belimumabIBA
07/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2021
1Biological ProductsIBA
07/2021
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
07/2021
1Tacrolimus (Prograf)FDA LinkGeneric
07/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2021
1Angiotensin Receptor AntagonistsIBA
07/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1DNA-Directed RNA Polymerases (RNA Polymerase)IBA
12/2020
1Complement System Proteins (Complement)IBA
12/2020
1Prion ProteinsIBA
10/2020
1LigandsIBA
10/2020
1Adalimumab (Humira)FDA Link
02/2020

Therapy/Procedure

17Therapeutics
01/2022 - 10/2012
2Physical Therapy Modalities (Physical Therapy Technique)
09/2016 - 03/2016
1Intramuscular Injections
02/2022